中東およびアフリカの契約製造市場、製品別（医薬品製造および医療機器製造）、エンドユーザー別（製薬会社、バイオテクノロジー会社、バイオ医薬品会社、医療機器会社、OEM、研究機関）、流通チャネル別（小売販売、直接入札、その他） - 2030 年までの業界動向と予測。
中東およびアフリカの契約製造市場の分析と洞察
中東およびアフリカの契約製造市場は、医薬品およびパイプライン製品の技術進歩とコスト効率の向上による需要の高まり、および研究開発への投資の増加によって市場が成長するなどの要因によって推進されています。現在、先進国および新興国全体で医療費が増加しており、メーカーが新しい革新的な製品を開発するための競争上の優位性が生まれることが期待されています。
契約製造とは、企業と製造業者の間で、指定された期間内に企業のために一定数の部品または製品を製造する契約です。製造された商品は、企業のラベルまたはブランドで販売されます。これはプライベート ラベル製造と呼ばれます。国境を越えて行われる場合は、アウトソーシングとも呼ばれます。製造業者は、顧客が独自の設計、処方、仕様を提供しない限り、独自の設計、処方、仕様に基づいてサービスを提供します。製造業者は、競合企業であっても、契約した相手にこれらの製品を作成します。
契約製造市場の成長を牽引する主な要因の 1 つは、医療機器および医薬品セクターにおける世界的な需要の高まりです。いくつかの企業がより良い診断のために行っている継続的な臨床試験研究は、市場の拡大につながります。市場は、技術の進歩とコスト効率の向上にも影響されます。ただし、機密情報のリスクと厳格な規制は、予測期間中に中東およびアフリカの契約製造市場の抑制要因として機能する可能性があります。
一方、特許の期限切れやジェネリック医薬品の需要増加、医療インフラの費用増加、主要市場プレーヤーによる戦略的取り組みは、市場の成長の機会となります。しかし、知的財産リスクや独自の製造ユニットを設立する製薬会社の増加は、中東およびアフリカの契約製造市場に課題をもたらす可能性があります。
ポイントオブケア診断への傾向の高まりにより、受託製造の需要は世界的に増加するでしょう。さまざまな企業が徐々に市場の成長につながる取り組みを行っています。
中東およびアフリカの契約製造市場は支援的であり、医療機関の製造努力の削減を目指しています。データブリッジマーケットリサーチは、中東およびアフリカの契約製造市場は2023年から2030年の予測期間中に5.3％のCAGRで成長すると分析しています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
売上高は百万米ドル、価格は米ドル |
|
対象セグメント |
製品別（医薬品製造および医療機器製造）、エンドユーザー別（製薬会社、バイオテクノロジー会社、バイオ医薬品会社、医療機器会社、OEM、研究機関）、流通チャネル別（小売販売、直接入札、その他） |
|
対象国 |
サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、その他の中東およびアフリカ諸国 |
|
対象となる市場プレーヤー |
Aenova Group、Thermo Fisher Scientific Inc.、EVONIK INDUSTRIES AG、Lonza、Boehringer Ingelheim Biopharmaceuticals GmbH、Catalent, Incなど |
中東およびアフリカの契約製造の動向
市場の定義
国際市場での契約製造は、ある会社が別の国の別の会社に自社製品の製造を依頼する場合に使用されます。これは、国際下請けまたは国際アウトソーシングとも呼ばれます。会社は製造業者にすべての仕様を提供し、該当する場合は製造プロセスに必要な材料も提供します。このタイプの契約では、製品の品質、認証、数量、条件、納期などに関して製造業者が満たさなければならない要件が規定されます。また、製造を委託する会社またはその顧客が定める製品の検査およびテストのガイドラインも確立されます。さらに、注文の変更、契約違反の場合の保証および補償も概説されます。このプロセスは基本的に、最終製品をプライベートブランド化するパートナーに海外市場での製造をアウトソーシングすることであるため、このタイプの契約を利用できるさまざまな会社や業界があります。
ドライバー
- 製造企業にとってのコスト効率
時間のかかる製造と、複数のものに対する非効率的な生産および管理は、公共部門および民間部門の組織にとって大きな負担です。また、単一の組織では変化を推進し、時には必要な結果を得るのに効果的ではないため、複雑な課題に対処するためにも契約製造会社は不可欠です。契約製造会社は、政府部門と民間部門の両方にとって新たな機会として機能します。
精度が向上し、時間的制約が緩和された契約製造の需要が高まるにつれ、主要プレーヤーは戦略的な取り組みを迫られています。契約製造を所有することで、機械、材料、その他の労働力への投資に必要な諸経費が削減され、生産プロセスが簡素化され、全体的なコストが削減されてサプライ チェーンが合理化されます。
しかし、大手市場プレーヤーは、エンドユーザーの需要を満たすために製造に多額の資本を投入しています。契約製造プレーヤーは、戦略の立案と実行に関与し、プレーヤーの生産コストを削減します。他の企業への契約製造サービスでは、生産サイクルに必要な効果的な労働力、戦略的インテリジェンス、または作業リソースを使用することで、リソースの効率と最適な使用も保証されます。
- 契約製造における技術進歩の台頭
製薬業界の需要が急増しているため、新薬を迅速に市場に投入するには、製造に多額の投資が必要です。一部の薬は処方が複雑で、大量生産には特別な設備と技術が必要となるため、高度な技術とスキルが必須です。
医薬品の開発や医療機器の製造において、機械学習、ビッグデータ、人工知能などの革新的な技術を迅速かつ迅速に活用することが検討されています。これらの技術の進歩は、短期間での大量生産と拡張性にも役立ちます。
しかし、製薬会社は通常、契約製造組織の生産および配送プロセスを監査または監督し、リアルタイムのリモート追跡を使用して製造プロセスを監視しています。
機会
- 医療インフラ整備にかかる費用の増加
インフラストラクチャは、すべての患者のケアと健康水準の向上、そして優れた医療システムの体験を促進するという基本目標を支える重要な柱です。同時に、医療システムとスタッフは、人口全体の効果的な健康促進、予防、セルフケアをサポートする必要があります。インフラストラクチャは、急性期および入院患者のケアの中心である病院をより広範な医療システムに統合し、質の高い患者体験、有効性、効率性、適時性、安全性、公平性、持続可能性の 7 つの領域を促進する必要があります。インフラストラクチャには、構築された環境と、機器、アクセス、情報技術 (IT)、システムとプロセス、持続可能性の取り組み、スタッフなどのサポート要素が含まれます。
しかし、医療インフラの開発にかかる費用の増加は、予測期間中の中東およびアフリカの契約製造市場の成長を促進しています。
制約/課題
- 医薬品製造拠点の設置数増加
Most pharmaceutical companies are building manufacturing sites to produce pharmaceutical products to reduce costs. Manufacturers are more focused on introducing advanced technologies and the digitalization process. The Pharma industry also faces disruptions due to new business models and a more focused population on personalized medicines and treatments. Hence, the demand for personalized care is high. Occupational profiles are also changing: some jobs are disappearing due to automation while entirely new jobs are emerging.
Hence, the increasing number of pharmaceutical companies setting up their manufacturing units may challenge the growth of the Middle East and Africa contract manufacturing market in the forecast period.
Recent Developments
- In October 2021, Boehringer Ingelheim International gmbh., had inaugurated its state-of-the-art biopharmaceutical production facility Large Scale Cell Culture (LSCC) in Vienna, Austria, with an investment volume of more than 700 million EUR, which is the single largest investment in the company's history
- In March 2023, Evonik Industries AG has announced that it is opening a new GMP facility to manufacture lipids for advanced, pharmaceutical drug delivery applications. The lipid launch facility is located at the company’s site in Hanau, Germany and provides customers with quantities of lipids as needed for clinical and small-scale commercial manufacturing
Middle East and Africa Contract Manufacturing Market Segmentation
The Middle East and Africa contract manufacturing market is categorized into three notable segments based on product, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product
- Medical Device Manufacturing
- Pharmaceutical Products Manufacturing
On the basis of product, the Middle East and Africa contract manufacturing market is segmented into medical device manufacturing and pharmaceutical products manufacturing.
End User
- Pharmaceutical Companies
- Biotechnology Companies
- Biopharma Companies
- Medical Device Companies
- Original Equipment Manufacturer
- Research Institutes
On the basis of end user, the Middle East and Africa contract manufacturing market is segmented into original equipment manufacturer, medical device companies, pharmaceutical companies, biotechnology companies, biopharma companies, and research institutes.
Distribution Channel
- Retail Sales
- Direct Tender
- Others
On the basis of distribution channel, the Middle East and Africa contract manufacturing market is segmented into direct tenders, retail sales, and others.
Middle East and Africa Contract Manufacturing Market Regional Analysis/Insights
The Middle East and Africa contract manufacturing market is analyzed, and market size insights and trends are provided by product, end user, and distribution channel as referenced above.
契約製造レポートで取り上げられている国には、サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、その他の中東およびアフリカ諸国などがあります。
発展途上地域での技術進歩の進展により、南アフリカが優位に立つことが予想されます。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、中東およびアフリカのブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、国内関税と貿易ルートの影響を考慮しながら、国別データの予測分析を提供します。
競争環境と中東およびアフリカの契約製造市場シェア分析
中東およびアフリカの契約製造市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、中東およびアフリカでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、中東およびアフリカの契約製造市場に対する会社の重点にのみ関連しています。
この市場のプレーヤーとしては、Aenova Group、Thermo Fisher Scientific Inc.、EVONIK INDUSTRIES AG、Lonza、Boehringer Ingelheim Biopharmaceuticals GmbH、Catalent, Inc などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC INITIATIVES:
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO BY FDA
5.2 REGULATORY SCENARIO IN AUSTRALIA
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING
6.1.3 MIDDLE EAST & AFRICA PRESENCE AND CONNECTED NETWORK
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS
6.2.2 RISK OF CONFIDENTIAL INFORMATION
6.3 OPPORTUNITIES
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 INTELLECTUAL PROPERTY RISKS
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES
7 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING
7.2.1 TYPES OF PRODUCTS
7.2.1.1 TABLETS
7.2.1.2 CAPSULES
7.2.1.3 BIOLOGICS
7.2.1.4 SMALL MOLECULE
7.2.1.5 CELL & GENES MANUFACTURING
7.2.1.6 NUTRACEUTICALS
7.2.1.7 OTHERS
7.2.2 TYPE OF SERVICES
7.2.2.1 DRUG DEVELOPMENT SERVICES
7.2.2.2 TABLET MANUFACTURING SERVICES
7.2.2.3 BIOLOGICS API MANUFACTURING
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES
7.2.2.5 OTHERS
7.2.3 BY DOSAGE FORM
7.2.3.1 SOLID FORMULATIONS
7.2.3.2 LIQUID FORMULATIONS
7.2.3.2.1 INJECTABLE
7.2.3.2.2 SYRUPS
7.2.3.3 SEMI-SOLID FORMULATIONS
7.2.3.4 TOPICAL DRUG FORMULATIONS
7.2.3.5 OTHERS
7.3 MEDICAL DEVICE MANUFACTURING
7.3.1 TYPE OF DEVICES
7.3.1.1 SYRINGES AND NEEDLES
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES
7.3.1.4 DISPOSABLES
7.3.1.5 IVD DEVICES
7.3.1.6 CARDIOVASCULAR DEVICES
7.3.1.7 DIABETES CARE DEVICES
7.3.1.8 GENERAL SURGERY DEVICES
7.3.1.9 ORTHOPEDIC DEVICES
7.3.1.10 RESPIRATORY DEVICES
7.3.1.11 OPHTHALMIC DEVICES
7.3.1.12 DENTAL DEVICES
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES
7.3.1.14 LABORATORY EQUIPMENT
7.3.2 TYPE OF SERVICES
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT
7.3.2.2 DEVICE ASSEMBLY
7.3.2.3 REGULATORY ASSISTANCE
7.3.2.4 PACKAGING & LABELLING
7.3.2.5 STERILIZATION SERVICES
7.3.2.6 TRAINING AND VALIDATION
7.3.2.7 QUALITY ASSURANCE
7.3.2.8 OTHERS
7.3.3 BY DEVICE CLASS
7.3.3.1 CLASS I MEDICAL DEVICES
7.3.3.2 CLASS IIA MEDICAL DEVICES
7.3.3.3 CLASS IIB MEDICAL DEVICES
7.3.3.4 CLASS III MEDICAL DEVICES
8 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER
8.1 OVERVIEW
8.2 PHARMACEUTICAL COMPANIES
8.3 BIOTECHNOLOGY COMPANIES
8.4 BIOPHARMA COMPANIES
8.5 MEDICAL DEVICES COMPANIES
8.6 ORIGINAL EQUIPMENT MANUFACTURER
8.7 RESEARCH INSTITUTES
9 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 RETAIL SALES
9.3 DIRECT TENDER
9.4 OTHERS
10 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY REGION
10.1 MIDDLE EAST AND AFRICA
10.1.1 SOUTH AFRICA
10.1.2 SAUDI ARABIA
10.1.3 U.A.E.
10.1.4 EGYPT
10.1.5 ISRAEL
10.1.6 REST OF MIDDLE EAST AND AFRICA
11 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 AENOVA GROUP
13.1.1 COMPANY SNAPSHOT
13.1.2 COMPANY SHARE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 EVONIK INDUSTRIES AG
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 LONZA
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 ABBVIE INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 ALMAC GROUP
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 AVID BIOSERVICES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 BAXTER
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.1 CATALENT, INC
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 FAMAR HEALTH CARE SERVICES
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 JUBILANT PHARMA LIMITED
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 KIMBALL INTERNATIONAL
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 MERCK KGAA
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 NIPR0
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 PFIZER INC
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 RECIPHARM AB.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
13.18 SIEGFRIED HOLDING AG
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 TE CONNECTIVITY
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENT
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, 2021-2030, 2021-2030 (UNIT)
TABLE 29 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP
TABLE 30 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 32 MIDDLE EAST AND AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 36 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 37 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 SOUTH AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 45 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 46 SOUTH AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 SOUTH AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 SOUTH AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 SOUTH AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 52 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 53 SOUTH AFRICA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 SOUTH AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 56 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 57 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 61 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 62 SAUDI ARABIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 SAUDI ARABIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 SAUDI ARABIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 SAUDI ARABIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 68 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 69 SAUDI ARABIA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 SAUDI ARABIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 72 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 UA.E. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 UA.E. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 77 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 78 UA.E. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 UA.E. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 UA.E. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 UA.E. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 84 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 85 UA.E. TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 UA.E. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 UA.E. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 UA.E. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 89 EGYPT CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 EGYPT PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 93 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 94 EGYPT BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 EGYPT BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 EGYPT LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 EGYPT MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 100 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 101 EGYPT TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 EGYPT BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 EGYPT CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 104 EGYPT CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 105 ISRAEL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 ISRAEL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 109 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 110 ISRAEL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 ISRAEL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 ISRAEL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 ISRAEL MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 116 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 117 ISRAEL TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 118 ISRAEL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 ISRAEL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 ISRAEL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 121 REST OF MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 RISING TECHNOLOGICAL ADVANCEMENTS AND COST-EFFECTIVENESS OF PHARMACEUTICAL AND MEDICAL PRODUCTS ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
FIGURE 12 THE PHARMACEUTICAL PRODUCTS MANUFACTURING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR CONTRACT MANUFACTURING MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
FIGURE 16 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2022
FIGURE 17 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 19 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, 2022
FIGURE 21 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 23 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 25 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 27 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 29 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 30 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 31 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 32 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
